Anti- and pro-inflammatory considerations in antidepressant use during medical illness: bupropion lowers and mirtazapine increases circulating tumor necrosis factor-alpha levels.
Kast
R E
RE
Department of Psychiatry, University of Vermont, Burlington, VT, USA. rekast@email.com
D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000523:psychology; D016642:Bupropion / Q000008:administration & dosage / Q000009:adverse effects*; D003424:Crohn Disease / Q000276:immunology / Q000523:psychology; D003866:Depressive Disorder / Q000188:drug therapy* / Q000276:immunology / Q000523:psychology; D006801:Humans; D007249:Inflammation / Q000139:chemically induced* / Q000276:immunology / Q000517:prevention & control*; D008803:Mianserin / Q000009:adverse effects* / Q000031:analogs & derivatives*; D000078785:Mirtazapine; D009369:Neoplasms / Q000276:immunology / Q000523:psychology; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D000928:Antidepressive Agents; D014409:Tumor Necrosis Factor-alpha; D016642:Bupropion; D008803:Mianserin; D000078785:Mirtazapine